저자의 연구 키워드

저자의 연구 키워드

#: Anemia

#가성 장폐색

#고령산모

#기종성

#농흉

#리네클리드

#산과 분만

#산모연령

#신우신염

#역학

#위유암종

#유산증

#저체중출생아

#출생력

#Amlodipine

#Amyloidosis

#Angiotensin II type 1 receptor blockers

#Angiotensin receptor antagonists

#Atherosclerosis

#Birth history

#Birth weight

#Calcium channel blocker

#Carbol fuchsin

#Carcinoid tumor

#Cardiovascular mortality

#Carotid arteries

#Castleman’s disease

#Chemotherapy

#chronic

#Chronic renal insufficiency

#Crescent

#Cutis marmorata telangiectatica congenita

#Cyclophosphamide

#Diabetes mellitus

#Diabetic nephropathies

#Dialysis

#Efonidipine

#Emphysematous

#Empyema

#Epidemiology

#Gastric pseudo-obstruction

#Gemcitabine

#Glomerular filtration rate

#Glomerulonephritis

#Hemodiafiltration

#Hospital mortality

#Hypertension

#Hypokalemic paralysis

#Hypokalemic periodic paralysis

#IgA

#IgA nephropathy

#Intestinal

#Kidney

#Kidney biomarkers

#Kidney failure

#Kidney injury molecule-1 (KIM-1)

#Lactic acidosis

#Linezolid

#Low birth weight infant

#Maternal ages

#Mortality

#Nephrotic syndrome

#Non-diabetic renal disease

#Non-small cell lung carcinoma

#Nutritional status

#Obstetric delivery

#Onychodysplasia

#Peritoneal dialysis

#Peritoneal equilibration test

#Peritoneal solute transport rate (PSTR)

#PET

#Phenol

#Plasma cells

#Prednisolone

#Proteinuria

#Pyelonephritis

#Renal dialysis

#Renal function

#Safety

#Sodium-glucose transporter 2 inhibitors

#Sodium-glucose transporter-2 inhibitors

#Steroid

#Telangiectasia

#Thyrotoxic periodic paralysis

#Treatment outcome

#type 2

#Ultrasound

#Vascular malformations